Ckd Bio (063160) — Cash Flow Quality Index
Ckd Bio (063160) has a Cash Flow Quality Index of -5.50x as of March 2025. Operating cash flow of ₩-4.95 Billion is below net income of ₩900.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Ckd Bio cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ckd Bio Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Ckd Bio across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ckd Bio (063160) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Ckd Bio (2008–2024)
Year-by-year earnings quality comparison for Ckd Bio. For live market cap and the full company financial profile, see 063160 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.61x | ₩14.03 Billion | ₩8.70 Billion | ▲ +107.5% |
| 2020 | 0.78x | ₩4.82 Billion | ₩6.21 Billion | ▼ -43.9% |
| 2019 | 1.39x | ₩16.99 Billion | ₩12.26 Billion | ▼ -29.1% |
| 2018 | 1.95x | ₩15.54 Billion | ₩7.96 Billion | ▼ -23.4% |
| 2017 | 2.55x | ₩20.45 Billion | ₩8.02 Billion | ▲ +55.2% |
| 2016 | 1.64x | ₩15.50 Billion | ₩9.43 Billion | ▼ -23.8% |
| 2015 | 2.16x | ₩14.34 Billion | ₩6.65 Billion | ▼ -67.3% |
| 2013 | 6.59x | ₩10.92 Billion | ₩1.66 Billion | ▲ +104.4% |
| 2012 | 3.22x | ₩22.90 Billion | ₩7.10 Billion | ▲ +171.7% |
| 2011 | 1.19x | ₩12.96 Billion | ₩10.92 Billion | ▼ -28.6% |
| 2010 | 1.66x | ₩23.89 Billion | ₩14.38 Billion | ▲ +1.2% |
| 2009 | 1.64x | ₩26.57 Billion | ₩16.18 Billion | ▲ +34.2% |
| 2008 | 1.22x | ₩10.69 Billion | ₩8.74 Billion | — |